Triple-negative breast cancer (TNBC) is characterized by a lack of the estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (Her2) expression and/or amplification [1]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.